论文部分内容阅读
硫普罗宁近年来在临床上应用越来越广泛,尤其是其在抗化疗肝损害方面的作用得到日益重视。我们观察了它对肺癌化疗药物性肝功能损害的防治作用,现报道如下。1资料与方法1.1预防肝损害收集丹东市第一医肿瘤科2004年2月-2010年12月收治的142例肺癌患者,其中男102例,女30例;年龄37～76岁,平均(54.1±15.3)岁。肺癌分期:I期29例,Ⅱ期34
Tiopronin has been used more and more widely in clinical practice in recent years, and its role in anti-chemotherapy liver damage has been increasingly valued. We have observed its preventive and therapeutic effects on lung cancer chemotherapy-induced liver damage, which are reported below. 1 Materials and methods 1.1 Prevention of liver damage collected 142 cases of lung cancer patients admitted to the first medical oncology department of Dandong City from February 2004 to December 2010, including 102 males and 30 females; aged 37 to 76 years old, average (54.1 ±15.3) years old. Stages of lung cancer: 29 cases of stage I, 34 of stage II